Xiaolong Li

784 citations
48 papers · 492 indexed · h-index 13
Topics
MicroRNA in disease regulation (6 papers)Circular RNAs in diseases (5 papers)Venomous Animal Envenomation and Studies (4 papers)
Partner nations
ChinaUnited StatesMexico

In The Last Decade

Xiaolong Li

44 papers receiving 487 citations

Peers

Xiaolong Li
Comparison fields: 5 of 92
  • Molecular Biology 288
  • Cancer Research 115
  • Oncology 99
  • Immunology 56
  • Pulmonary and Respiratory Medicine 54
Replace Rossella Titone with:
Rossella Titone United States
Qin Yang China
Marie Bénéteau France
Xiaoyan Gu China
Yani Zhao China
Yuexin Xu China
Hyun‐Jung An South Korea
Elena Palma United Kingdom
Won Suk Yang South Korea
Xiaolong Li relative to Rossella Titone United States Rossella Titone's profile →
Citations per field
00.5×1.5×2.2×
Rossella Titone · 1×
Citations per year

Countries citing papers authored by Xiaolong Li

Since Specialization
Citations

This map shows the geographic impact of Xiaolong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Li more than expected).

Fields of papers citing papers by Xiaolong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Li. The network helps show where Xiaolong Li may publish in the future.

Co-authorship network of co-authors of Xiaolong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolong Li. A scholar is included among the top collaborators of Xiaolong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolong Li. Xiaolong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 2
5 9
6 1
7 1
8 2
9 6
10 1
11 23
12 8
13 5
14 20
15 7
16 45
17 18
18
Gab2-Akt-ARK5 signaling pathway is associated with the invasion of glioma cells
1
19 29
20 92

About Xiaolong Li

Xiaolong Li is a scholar working on Cancer Research, Molecular Biology and Cell Biology, having authored 48 papers that have together received 492 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers) and Venomous Animal Envenomation and Studies (4 papers). The work is most often cited by research in Cancer Research (115 citations), Clinical Biochemistry (33 citations) and Molecular Biology (288 citations). Xiaolong Li has collaborated with scholars based in China, United States and Mexico. Frequent co-authors include Qingfeng Ni, Jianwei Zhu, Wei‐Yi Chen, Yuqing Liu, Guohua Lü, Chonggao Yin, Hongli Li, Shijun Lu, Baogang Zhang and Lei Sun. Their work appears in journals such as Cancer Research, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026